Tokyo Tape
Sign in
← Fuso Pharmaceutical Industries

Annual report

4538.TEDINET S100TRL6
Period2023-04-01 → 2024-03-31
Filed2024-06-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
MetricValuePeriodScopeSource row
Revenue¥55.4bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥51.0bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥49.6bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥49.3bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥46.9bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥2.0bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥2.2bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥1.9bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥2.2bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥2.0bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.2bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.1bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥1.8bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥2.2bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥1.4bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥1.6bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥1.6bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥707m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥75.8bnat 2024-03-31StandaloneAssets
Total assets¥72.5bnat 2023-03-31StandaloneAssets
Total assets¥69.3bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥69.9bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥69.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥39.1bnat 2024-03-31StandaloneLiabilities
Total liabilities¥36.8bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥36.7bnat 2024-03-31StandaloneNet assets
Net assets / equity¥35.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥34.5bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥33.7bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥32.3bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥5.1bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥8.0bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥5.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥8.0bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥7.3bnat 2022-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥7.1bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥7.3bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥627m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥2.9bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥3.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.2bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥5.7bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.5bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.4bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.6bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥978m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.5bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥14m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥813m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.7bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.4bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.8bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥159.982023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.072022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥169.092021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥183.182020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥80.592019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥702023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥602021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,290.55at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,064.76at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥3,936.7at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,839.54at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,681.46at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio48.4%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.8%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio46.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.8%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE4.6%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE4.3%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE4.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.2%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued9,451,169at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,451,169at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees1,307at 2024-03-31StandaloneNumber of employees
Employees1,314at 2023-03-31StandaloneNumber of employees
Employees1,344at 2022-03-31dStandaloneNumber of employees
Employees1,356at 2021-03-31dStandaloneNumber of employees
Employees1,352at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2024-03-311247 pure
Real Estate Businessreportable segmentemployeesat 2024-03-311 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,027
ItemContextValueUnit
Deferred tax assetsCurrentYearInstant_NonConsolidatedMember396000000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember1307000000JPY
Other ioaCurrentYearInstant_NonConsolidatedMember1232000000JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember5153000000JPY
Investments and other assetsCurrentYearInstant_NonConsolidatedMember5826000000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember29246000000JPY
Noncurrent assetsCurrentYearInstant_NonConsolidatedMember30854000000JPY
AssetsPrior1YearInstant_NonConsolidatedMember72466000000JPY
AssetsCurrentYearInstant_NonConsolidatedMember75802000000JPY
Notes payable tradePrior1YearInstant_NonConsolidatedMember1481000000JPY
Notes payable tradeCurrentYearInstant_NonConsolidatedMember1822000000JPY
Electronically recorded obligations operating clPrior1YearInstant_NonConsolidatedMember8634000000JPY
Electronically recorded obligations operating clCurrentYearInstant_NonConsolidatedMember9074000000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember4564000000JPY
Accounts payable tradeCurrentYearInstant_NonConsolidatedMember5530000000JPY
Short term loans payablePrior1YearInstant_NonConsolidatedMember2350000000JPY
Short term loans payableCurrentYearInstant_NonConsolidatedMember2350000000JPY
Current portion of long term loans payablePrior1YearInstant_NonConsolidatedMember3313000000JPY
Current portion of long term loans payableCurrentYearInstant_NonConsolidatedMember3351000000JPY
Accounts payable otherPrior1YearInstant_NonConsolidatedMember990000000JPY
Accounts payable otherCurrentYearInstant_NonConsolidatedMember1148000000JPY
Accrued expensesPrior1YearInstant_NonConsolidatedMember409000000JPY
Accrued expensesCurrentYearInstant_NonConsolidatedMember376000000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember426000000JPY
Income taxes payableCurrentYearInstant_NonConsolidatedMember270000000JPY
Deposits receivedPrior1YearInstant_NonConsolidatedMember42000000JPY
Deposits receivedCurrentYearInstant_NonConsolidatedMember42000000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember930000000JPY
Provision for bonusesCurrentYearInstant_NonConsolidatedMember922000000JPY
Provision for directors bonusesPrior1YearInstant_NonConsolidatedMember21000000JPY
Provision for directors bonusesCurrentYearInstant_NonConsolidatedMember20000000JPY
Notes payable facilitiesPrior1YearInstant_NonConsolidatedMember1222000000JPY
Notes payable facilitiesCurrentYearInstant_NonConsolidatedMember989000000JPY
Other clPrior1YearInstant_NonConsolidatedMember4086000000JPY
Other clCurrentYearInstant_NonConsolidatedMember3751000000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember28474000000JPY
Current liabilitiesCurrentYearInstant_NonConsolidatedMember29650000000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember5747000000JPY
Long term loans payableCurrentYearInstant_NonConsolidatedMember7021000000JPY
Deferred tax liabilities for land revaluationPrior1YearInstant_NonConsolidatedMember1315000000JPY
Deferred tax liabilities for land revaluationCurrentYearInstant_NonConsolidatedMember1315000000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember879000000JPY
Provision for retirement benefitsCurrentYearInstant_NonConsolidatedMember736000000JPY
Provision for directors retirement benefitsPrior1YearInstant_NonConsolidatedMember168000000JPY
Provision for directors retirement benefitsCurrentYearInstant_NonConsolidatedMember153000000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember108000000JPY
Asset retirement obligations nclCurrentYearInstant_NonConsolidatedMember108000000JPY
Other nclPrior1YearInstant_NonConsolidatedMember123000000JPY
Other nclCurrentYearInstant_NonConsolidatedMember153000000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember8343000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass